Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.07M Buy
+44,500
New +$2.06M ﹤0.01% 3173
2024
Q4
Sell
-5,600
Closed -$227K 4525
2024
Q3
$227K Buy
+5,600
New +$211K ﹤0.01% 4100
2023
Q4
Sell
-65,000
Closed -$2.46M 4392
2023
Q3
$2.46M Buy
+65,000
New +$2.65M ﹤0.01% 2409
2021
Q1
Sell
-12,057
Closed -$363K 4173
2020
Q4
$363K Sell
12,057
-5,328
-31% -$157K ﹤0.01% 3528
2020
Q3
$443K Buy
+17,385
New +$461K ﹤0.01% 3283
2016
Q1
Sell
-11,777
Closed -$233K 3527
2015
Q4
$233K Hold
11,777
﹤0.01% 3493
2015
Q3
$249K Hold
11,777
﹤0.01% 3415
2015
Q2
$264K Hold
11,777
﹤0.01% 3470
2015
Q1
$282K Sell
11,777
-112,160
-90% -$2.78M ﹤0.01% 3328
2014
Q4
$3.28M Sell
123,937
-56,080
-31% -$1.44M ﹤0.01% 1885
2014
Q3
$4.38M Hold
180,017
0.01% 1658
2014
Q2
$4.68M Buy
180,017
+168,240
+1,429% +$4.29M 0.01% 1676
2014
Q1
$282K Sell
11,777
-36,732
-76% -$773K ﹤0.01% 3941
2013
Q4
$948K Sell
48,509
-203,851
-81% -$4.1M ﹤0.01% 3217
2013
Q3
$5.33M Sell
252,360
-86,924
-26% -$1.9M 0.01% 1531
2013
Q2
$7.47M Buy
+339,284
New +$8.23M 0.01% 1064

Other funds holding EXC

David Shaw's EXC Position: Q2 2026 in Review

David Shaw reduced its Exelon (EXC) stake by 8.5% in Q2 2026, selling an estimated $223K and leaving 51,927 shares worth $2.42M. The position accounts for ﹤0.01% of the portfolio, ranked #3043.

David Shaw first reported a position in EXC in Q2 2013 and has held it in 48 quarters since. The position peaked at $183M in Q4 2019. 1,284 funds tracked by Wall St. Rank hold EXC as of Q2 2026.

  • David Shaw held 51,927 shares of Exelon worth $2.42M as of Q2 2026.
  • David Shaw sold 4,816 Exelon shares in Q2 2026, an estimated $223K.
  • Exelon made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #3043 holding.
  • David Shaw first reported a position in Exelon in Q2 2013 and has held it in 48 quarters since.
  • David Shaw's Exelon position peaked at $183M in Q4 2019.
  • 1,284 funds tracked by Wall St. Rank held Exelon as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.